SİNEM OZTURKLER | Health Professions | Best Researcher Award

Posted on by Forensic Scientist

Assist. Prof. Dr. SİNEM OZTURKLER | Health Professions | Best Researcher Award

University of Kocaeli | Turkey

Dr. Sinem Öztürkler is a dedicated academic and healthcare professional specializing in child health and diseases nursing. With a profound background in nursing and a growing research portfolio, she has committed her career to enhancing maternal and child health outcomes through education, innovation, and interdisciplinary collaboration. Currently serving at Kocaeli University, she actively contributes to academic growth, scientific advancement, and healthcare education in Turkey and internationally.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

Lect. PhD Sinem Öztürkler demonstrates commendable academic and research credentials, especially in the field of pediatric and maternal health nursing. Her doctoral dissertation on obsessive-compulsive behaviors and breastfeeding self-efficacy reflects an original contribution to nursing science. She has multiple peer-reviewed publications, including in high-impact journals such as the Journal of Pediatric Nursing (2024, SCI-Expanded) and Healthcare for Women International (2022, SSCI), indicating both international visibility and relevance of her research topics. Her contributions span across burnout in pediatric nurses, maternal fatigue, and nursing care during pandemics, addressing critical and timely healthcare issues. She has also co-authored a book chapter on childhood immunization, further enriching academic literature.

🎓 Education

Dr. Öztürkler holds a Ph.D. from Sakarya University, Institute of Health Sciences (2019–2023), where her research focused on obsessive-compulsive behaviors and breastfeeding self-efficacy in mothers of preterm and low birth weight infants. She earned her postgraduate degree from Halic University (2012–2014) and completed her undergraduate studies in Nursing at Balıkesir University (2007–2011). Her educational path reflects a strong commitment to health sciences and continuous learning.

💼 Experience

Since 2019, Dr. Öztürkler has been a Lecturer Ph.D. at Kocaeli University. Beyond her teaching duties, she contributes to institutional development as a member of the Department Quality Commission and the Adaptation/Exemption Committee. She also teaches key courses such as Pediatric Nursing and First Aid at undergraduate and associate levels. Her early clinical career began at Kocaeli University Hospital, where she worked as a nurse, bridging practice and academia.

🔬 Research Interests On Health Professions

Dr. Öztürkler’s research interests revolve around child health and diseases nursing, maternal mental health, breastfeeding self-efficacy, postpartum behaviors, and pediatric care challenges during disasters. She has participated in funded projects, such as the QR code-supported newborn care education program for mothers of preterm infants, demonstrating her innovative approach to maternal-child healthcare.

🏆 Awards

In 2023, Dr. Öztürkler was honored with the Mustela Foundation Midwifery and Nursing Award, recognizing her excellence in maternal and child health research. This prestigious award, shared with collaborators, highlights her impactful contributions to evidence-based nursing practices in Turkey.

📚 Publications

Journal Articles (SCI, SSCI, AHCI Indexed):

Other Journal Publications:

Book Chapter:

  • Öztürkler, S., & Dede Çınar, N. (2020). “Bağışıklama ve Aşılar.” In Anne ve Çocuk Sağlığı İlk 1000 Gün, Akademisyen Kitabevi, pp. 381–417.

📝 Conclusion

🌟 Lect. Dr. Sinem Öztürkler exemplifies the qualities of a committed academic and healthcare professional. With impactful research in pediatric and maternal health, award-winning initiatives, and active academic service, she is a strong contender for recognition in her field. Her dedication to advancing child health nursing and maternal well-being, both through empirical studies and educational innovations, marks her as a rising star in health sciences.

Sivahari Gorantla | Health Sciences | Best Researcher Award

Posted on by Forensic Scientist

Dr. Sivahari Gorantla | Health Sciences | Best Researcher Award

Dept Of Hematology And Oncology | Germany

Dr. Sivahari Prasad Gorantla, born on July 25, 1980, in India, is a Junior Group Leader at the Signal Transduction Lab at the University Medical Center, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. His research focuses on molecular therapeutics, targeted therapy, and drug resistance mechanisms. He is recognized for his groundbreaking work in the development of therapies targeting JAK2 and other kinases in myeloproliferative neoplasms.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Experience: Dr. Gorantla’s research spans a wide range of significant areas, including molecular therapeutics, cancer research, and drug resistance mechanisms, making him a key contributor to advancements in these fields.

  • Outstanding Publication Record: His research publications in high-impact journals such as Nature Communications, Leukemia, and Molecular Oncology highlight his ability to generate novel and impactful insights in his field.

  • International Recognition and Honors: Dr. Gorantla has received multiple awards, including the “Young Investigator Prize” from DGHO and the “Abstract Achievement Award” from the American Association of Hematology. His recognition by prestigious organizations indicates his high standing in the scientific community.

  • Successful Grant Acquisition: His ability to secure substantial research grants from prestigious sources (e.g., DAAD, DFG, Wegener Foundation) is a testament to his research credibility and the relevance of his work.

  • Teaching and Mentoring: His involvement in teaching medical students and master’s students, particularly in the areas of molecular life sciences and genomics, showcases his dedication to education and mentoring the next generation of researchers.

Education 🎓

Dr. Gorantla completed his Ph.D. in Hematology and Oncology from Klinikum rechts der Isar, TUM in 2010. He then pursued multiple postdoctoral fellowships, including at the University Clinic Freiburg and the prestigious Hematology and Oncology department at TUM. His academic journey also includes a Master’s in Biotechnology from the University of Calicut.

Experience 💼

Dr. Gorantla’s career spans several key positions, including Assistant Professor at the University of Hyderabad, India, and Independent Postdoctoral Fellow at University Clinic Freiburg. His work involves leading research in molecular mechanisms behind cancer resistance to therapy and the development of novel therapeutic strategies. He currently holds his position as Junior Group Leader at the University Medical Center Lübeck.

Research Interests On Health Sciences 🔬

Dr. Gorantla’s research revolves around molecular therapeutics, targeted therapy, and mechanisms of drug resistance, particularly in blood cancers like leukemia and myeloproliferative neoplasms. He has contributed to understanding the role of JAK2 and other kinases in resistance to treatment, paving the way for novel treatment strategies.

Awards 🏆

Throughout his career, Dr. Gorantla has earned several prestigious accolades. Notable among them are the Young Investigator Prize by DGHO (German Hematology Association) in 2010 and the Abstract Achievement Award from the American Association of Hematology in 2013. He has also been a finalist for the AACR Scholar-in-Training Award and won multiple travel awards at major hematology conferences.

Publications 📚

Dr. Gorantla has authored numerous impactful publications in the field of oncology. Some of his significant works include:

  • Gorantla SP, Rassner M, et al. Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is mediated mainly by targeting pro-inflammatory cytokine signaling not oncogenic signaling (Accepted in Nature Communications, 2024). Nature Communications

  • Gorantla SP, Oelschlager L, et al. Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation (Accepted in Leukemia, 2024). Leukemia Journal

  • Gorantla SP, Mueller TA, et al. A newly identified 45-kDa JAK2 variant (Mol Oncol, 2024). Mol Oncol
    His work is widely cited in the field, with articles being referenced by researchers and clinicians worldwide.

Conclusion 🌍

Dr. Sivahari Prasad Gorantla has emerged as a leader in the field of molecular oncology, particularly in the development of targeted therapies for blood cancers. His dedication to research, extensive experience, and numerous accolades make him a valuable contributor to scientific advancements in cancer treatment. With ongoing research grants and fellowships, Dr. Gorantla continues to push the boundaries of medical science, offering new hope for cancer patients worldwide.